Quantcast
Last updated on April 16, 2014 at 14:14 EDT

Latest Diabetes Stories

2014-03-21 08:24:51

Company Introduces Next-Generation OptiScanner 6000; Platform to Add Real-Time Monitoring of Key Hemodynamic Measures in ICU Settings BRUSSELS, March 21, 2014 /PRNewswire/ -- OptiScan Biomedical Corporation, a developer of innovative continuous monitoring systems for use in intensive care units (ICU)/critical care units (CCU), introduced its next-generation OptiScanner((TM) )product as part of a special symposium at the 34(th) International Symposium on Intensive Care and Emergency Medicine...

2014-03-20 23:03:54

The treatment study using autologous (the patient’s own) adult stem cells will be conducted in the USA in April and will be available to the general public. Dallas, TX (PRWEB) March 20, 2014 The Repair Stem Cells Institute (RSCI) -- http://www.repairstemcells.org -- is pleased to announce that it will assist interested patients to take part in a patient-sponsored research study based in the United States for the treatment of Type2 Diabetes with adult stem cells. The study, which meets...

2014-03-20 16:26:31

DALLAS, March 20, 2014 /PRNewswire-iReach/ -- RnRMarketResearch.com adds "Blood Glucose Device (SMBG) (Test Strips, Lancet, Meter) Market & Forecast - Worldwide" to its that says China has the highest number of self-monitoring blood glucose device users but United States has highest number of test strips market share. (Photo: http://photos.prnewswire.com/prnh/20140320/MN87221) Blood glucose monitoring devices market is very lucrative business with enormous future potential....

2014-03-20 12:32:35

Conference Call to begin at 9:00 a.m. ET PHILADELPHIA, Pa., March 20, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it will release financial results for the year ended December 31, 2013 on Thursday, March 27, 2014. Management will hold a conference call to review the company's 2013 performance starting at 9:00 a.m. ET...

2014-03-19 20:21:19

Health Researcher Blaine Tucker Announces Progress In Attempts To Control Diabetes MIAMI, March 19, 2014 /PRNewswire-iReach/ -- By Becky Guerro A recent announcement from health researcher Blaine Tucker may offer hope to people struggling to control diabetes. Tucker says that he will soon publish an in-depth report detailing the progress of his research into the links between diabetes and diet. "I want to make sure that this report is very accessible, this is information that...

2014-03-19 08:28:25

CARLSBAD, Calif., March 19, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has initiated a Phase 1 clinical study for ISIS-ANGPTL3(Rx), an antisense drug targeting angiopoietin-like 3 protein (ANGPTL3), an independent risk factor for cardiovascular disease. ISIS-ANGPTL3(Rx) is designed to act as a broad dyslipidemia agent. By reducing ANGPTL3, ISIS-ANGPTL3(Rx) has the potential to reduce LDL-cholesterol and triglycerides, and to increase...

2014-03-19 08:28:16

ALBANY, New York, March 19, 2014 /PRNewswire/ -- MarketResearchReports.Biz includes new market research report "Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its large collection of research report. http://www.marketresearchreports.biz/analysis-details/continuous-glucose-monitoring-cgm-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018 This report studies the...

2014-03-18 23:32:09

In Celebration, Company Offers Exclusive $4 Off Coupon Boulder, CO (PRWEB) March 18, 2014 Level Foods announced today that their full range of Level Life diabetes and life style food products are now available nationwide at Target Stores. To celebrate its Target distribution, the company is offering a limited time $4-off coupon on their newest line of LEVEL Life protein bars and shakes found in the diabetes aisle near the pharmacy. To download the coupon, simply visit...

2014-03-18 23:02:01

The firm is investigating Lipitor lawsuits on behalf of patients who allegedly developed new-onset Type 2 diabetes due to their use of Lipitor. New York, New York (PRWEB) March 18, 2014 As Lipitor lawsuits (http://www.thelipitorlawsuit.com/) continue to mount in federal court, Bernstein Liebhard LLP notes the publication of a new study that suggests an association between the use of statin drugs like Lipitor and the development of new-onset Type 2 diabetes. The research, which was...

2014-03-18 23:01:40

Those living with type II diabetes are needed for a paid medical study in Milwaukee Milwaukee, WI (PRWEB) March 18, 2014 Over the years, doctors have understood the importance of diabetes research and vital insights have been gained through extensive study. With diabetes more prevalent than ever, researchers at the Medical College of Wisconsin have launched several studies related to the complications of Type 2 diabetes. With detailed information gathered, the focus of the latest Medical...


Latest Diabetes Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (3 articles) »